Formulators know the headache. You add a potent active. The skin barrier panics. Erythema spikes. What is the solution? Absolute stability. We need immunomodulators that dissolve without a fight. Dipotassium Glycyrrhizinate (DPG) does exactly this.
It acts as a precise hyaluronidase inhibitor. It downregulates the NF-kB signaling pathway. The inflammatory cascade stops instantly. In vitro CCK-8 assays confirm normal epidermal cell viability remains stable. At a strict concentration of 10 μg/mL, DPG exhibits a 94.23% inhibition rate against ROS oxidative damage. [Molecules – https://www.mdpi.com/1420-3049/27/6/1914] No extracellular matrix degradation. No massive histamine dumps. Just pure erythema reduction.
Let’s look at the molecule. DPG binds two potassium ions to a triterpenoid saponin backbone. The result? Exceptional hydrophilicity. Pure glycyrrhizic acid precipitates constantly. Raw botanical extracts leave a mess in the beaker. Why complicate the formulation? DPG solves this entirely. It dissolves freely in cold water. Zero thermal degradation risks during high-shear emulsification.
| Parameter | Specification Benchmark | Analytical Method |
|---|---|---|
| Appearance | White to pale yellow fine powder | Visual Inspection |
| Assay (HPLC) | ≥ 98.0% | High-Performance Liquid Chromatography |
| pH Value (1% Solution) | 5.0 – 6.0 | Potentiometric Titration |
| Loss on Drying | ≤ 8.0% | 105°C, 2 Hours |
| Heavy Metals (Pb) | ≤ 10 ppm | Atomic Absorption Spectroscopy |
| Solubility | Freely soluble in water | Ph. Eur. Protocol |
Cosmetic chemistry is moving past single-target solutions. Multi-pathway action is the baseline. DPG is your foundational anti-erythema agent. It buffers aggressive actives. It widens the therapeutic window of harsh formulations.
Retinoids wreck the barrier. It is a known trade-off. Can we fix it? Yes. Add 0.2% – 0.5% DPG into the emulsion. It intercepts the COX-2 response before erythema peaks. Formulations maintain clinical efficacy without the peeling.
Post-procedure skin needs structure. Histological data proves DPG accelerates granulation and modulates collagen density. [Journal of Dermatological Science – https://pmc.ncbi.nlm.nih.gov/articles/PMC8516426/] Combine it with high-molecular-weight Oat Beta-Glucan. You get a biomimetic film. The active stays anchored at the stratum corneum boundary. Re-epithelialization speeds up massively.
Totarol destroys Cutibacterium acnes. But rapid bacterial lysis triggers localized swelling. Pair 0.1% Totarol with 0.5% DPG. The localized inflammatory exudate drops immediately. Post-inflammatory hyperpigmentation (PIH) is blocked at the source. [Biomedicine & Pharmacotherapy – https://pmc.ncbi.nlm.nih.gov/articles/PMC9965141/]
Sourcing dictates success. Procurement must demand rigorous batch testing. Here is actual representative analytical data. It proves standard pharmaceutical-grade cosmetic compliance.
| Test Item | Standard Criteria | Batch Result | Status |
|---|---|---|---|
| Assay (Anhydrous) | ≥ 98.0% | 98.6% | Complies |
| Chloride (Cl) | ≤ 0.014% | 0.008% | Complies |
| Sulfate (SO4) | ≤ 0.029% | 0.012% | Complies |
| Total Plate Count | ≤ 1000 cfu/g | < 100 cfu/g | Complies |
A1: Demand an HPLC assay of 98.0% minimum. This guarantees no unreacted extraction solvents. Heavy metals must sit strictly below 10 ppm.
A2: Vastly better. Those two potassium ions change the physical chemistry. DPG dissolves freely in cold water. Glycyrrhizic acid demands heat and specific solvent blends just to prevent crystallization.
A3: Keep the formula pH between 4.0 and 7.0. Go below pH 3.5, and the salt protonates back to the acid form. It will inevitably precipitate out of the solution.
A4: Hit between 0.1% and 1.0%. Toners and daily serums need 0.2% – 0.5%. Acute acne spot treatments can handle up to 1.0%.
A5: It affects the raw botanical yield. It does not affect the final molecule. Proper pharmaceutical extraction standardizes the powder to >98% purity. Geographic variance vanishes entirely.
A6: Yes. Fully compliant globally. The Cosmetic Ingredient Review (CIR) Expert Panel backs its safety. No phototoxicity. No sensitization potential.
A7: Yes. It blocks hyaluronidase. It suppresses IL-1 and IL-6. This directly stops vasodilation and matrix degradation immediately after acute UV exposure.
A8: Expect 7-14 days via air freight from verified facilities. Packaging must be vacuum-sealed and light-resistant. Never accept bulk transit without third-party HPLC verification.
Huatai Bio provides a comprehensive portfolio of high-efficacy cosmetic active ingredients, empowering global brands to create next-generation skincare formulations for high-end skincare formulation needs.
Comprehensive Solutions & Innovation: Our categories cover the full spectrum of market requirements: Anti-aging & Firming, Oil-Control & Anti-acne, Anti-inflammatory & Soothing,Antioxidant Defense, Brightening,and Hydration & Barrier Repair.We offer both established classics and cutting-edge actives.
Driven by a passion for scientific excellence, our state-of-the-art R&D laboratory is dedicated to exploring the frontier of bio-active molecules. Beyond supplying ingredients, we offer end-to-end formulation consultancy and customized solution development. Our team of expert chemists works closely with your brand to overcome complex stability issues and sensory challenges, ensuring your final product stands out in a competitive global market.
Uncompromising Quality & Credibility:We ensure every batch of our Active skincare ingredients meets rigorous quality standards, including COSMOS, ISO 9001/22000, and HALAL Certification. This commitment, backed by a complete Technical Dossier, offers clinically-backed solutions and guaranteed compliance for every formulation challenge.
Room 1901, Building 2, Wanda Plaza, Beilin District, Xi'an, Shaanxi.
Email: [email protected]
Phone: +86 17868678161
Copyright © 2026. Shaanxi Huatai Bio-Fine Chemical Co., Ltd. All Rights reserved.